OUR PRODUCTION
ASPEGON's production infrastructure includes the pilot-industrial B2B platform Apoem Biotech. This full-cycle technological complex provides the extraction and advanced purification of bioactive substances, from raw materials to bulk ingredients.
ASPEGON establishes and strictly locks manufacturing protocols for target compounds before transferring bulk ingredients to external mass production.
INFRASTRUCTURE & FACILITIES
The Apoem Biotech complex is designed as a full-cycle industrial platform and is equipped with advanced high-tech machinery.
Extraction Units
Efficient extraction of target substances from natural raw materials.
Vacuum Reactors
Controlled processing, fractionation, and stabilization of derived substances.
Industrial Filtration
Guaranteed premium purity level of the final product.
CAPACITY & ADAPTABILITY
The manufacturing lines ensure stable production of target substances:
AMI-LC-2763
Output up to 3,000 liters per year.
AMP-PC-2763
Output up to 190 kg per year.
The platform architecture is universal, allowing for rapid adaptation of production lines to manufacture alternative target products.
QUALITY STANDARDS & CONTROL
Guaranteed stability and reproducibility of every process for all types of compounds:
Standardization
Stable and fully validated technological process.
Target Concentration
Target Concentration
Verification
Analytical laboratory test reports.
